JB/CALL/BB BIOTECH N/50/0.0667/21.06.24 Share Price

Warrant

BIOQJB

CH1242802242

Market Closed - Swiss Exchange 16:20:01 21/05/2024 BST
0.005 CHF -16.67% Intraday chart for JB/CALL/BB BIOTECH N/50/0.0667/21.06.24
3 months-95.65%
6 months-75.00%

Static data

Product typeWarrant Plain-Vanilla
Buy / SellCALL
Underlying BB BIOTECH AG
Issuer Bank Julius Bär
BIOQJB
ISINCH1242802242
Date issued 10/03/2023
Strike 50 CHF
Maturity 21/06/2024 (6 Days)
Parity 14.99 : 1
Emission price 0.51 CHF
Emission volume N/A
Settlement entrambi
Currency CHF

Technical Indicators

Highest since issue 0.47 CHF
Lowest since issue 0.005 CHF
Spread 0.004 CHF
Spread %80.00%

Company Profile

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s portfolio comprises between 20 and 35 companies and includes such companies as Celgene, Actelion, Vertex Pharmaceuticals, Gilead, Novo Nordisk, Incyte, Isis Pharmaceuticals, Immunogen, Halozyme Therapeutics, Ariad Pharmaceuticals, Biomarin Pharmaceutical, Alexion Pharmaceuticals, Optimer Pharmaceuticals, Achillion Pharmaceuticals, Swedish Orphan Biovitrum, Dendreon, Bavarian Nordic, Lupin, Glenmark Pharmaceuticals, Strides Arcolab, Endocyte, Probiodrug, and Idenix Pharmaceuticals.
Sector
-
More about the company

Ratings for BB Biotech AG

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: BB Biotech AG

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
39.65 CHF
Average target price
47.7 CHF
Spread / Average Target
+20.30%
Consensus
  1. Stock Market
  2. Warrants
  3. BIOQJB Warrant
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW